Distillate Capital Partners announces Q4 2025 portfolio changes
Distillate Capital Partners announced portfolio changes for Q4 2025, including purchases and sales across various strategies. The U.S. Fundamental Stability & Value Composite acquired Bristol-Myers Squibb, Vistra, and TE Connectivity, while selling Elevance Health, HCA Healthcare, and Lowe's. The U.S. Small/Mid Cap Quality & Value Composite bought CF Industries, Molson Coors, and Toll Brothers, exiting Range Resources, Gap, and TopBuild. Internationally, the strategy added Agnico Eagle Mines, HD HYUNDAI, and Rio Tinto, divesting from SK Hynix, LVMH, and Aluminum Corporation of China. Changes also included adjustments in stakes for several companies.
Source: businessinsider The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments